Cefotaxime may also be used for purposes not listed in this medication guide.
Gloryfen is a drug made in Malta. You need a doctor's prescription to buy it. But its analogues can be bought online anywhere in the world without going to a specialist.
Cefotaxime is a complete analogue of Gloryfen. It has the same composition, dosage and methods of use. Also Cefotaxime has a lower cost compared to Gloryfen.
To buy Gloryfen, click on the "buy now" button and then in our online store select the medicine and the desired dosage. Follow the instructions below.
Free delivery is valid for purchases from $200. We deliver medicines around the world and provide the best prices.
You can also use a coupon giving a 5% discount.
Side effects
Get emergency medical help if you have even mild symptoms: headache, or diarrhea, itching, vomiting, stomach pain, loss of appetite, fever, yellowing eyes or skin, or
Warnings
Cefotaxime can pass into breast milk and may harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
This medicine is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Interactions
Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate. Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic. Consider therapy modification
BCG Vaccine (Immunization): Antibiotics may diminish the therapeutic effect of BCG Vaccine (Immunization). Monitor therapy
Vitamin K Antagonists (eg, warfarin): Cephalosporins may enhance the anticoagulant effect of Vitamin K Antagonists. Monitor therapy
Food interaction
Pregnancy
- Side effects, drug interactions, dosage, and pregnancy safety should be reviewed prior to taking this medication.
- Although maintenance use of tocolytics after acute suppression of contractions has not been shown to prolong pregnancy, doses of 10 to 20 mg PO every 4 to 6 hours have been used.
Overview
Before starting cefotaxime treatment, it should be established that the patient has a history of allergic reactions, especially cefotaxime, cephalosporins and penicillins (and other beta-lactam antibiotics), since hypersensitivity reactions develop in 5-10% of cases. Serious, including fatal, cases of hypersensitivity have been observed in patients taking cefotaxime.
If an allergic reaction develops, you should definitely stop using cefotaxime and, if necessary, conduct appropriate treatment. Particular caution should be observed in the case of the use of cefotaxime in patients with allergic diathesis or asthma.
The use of cefotaxime is absolutely contraindicated in the event of an immediate history of hypersensitivity to cephalosporins in history.
People with hypersensitivity to penicillins are also allergic to cephalosporins (the so-called cross allergy). In this case, there is a danger of developing a severe allergic reaction. Special care should be taken when using cefotaxime in patients who have developed hypersensitivity reactions (especially if an anaphylactic reaction has occurred) to penicillins or other beta-lactam antibiotics.
Serious blistering skin reactions
Serious cases of blistering reactions such as Stevens-Johnson syndrome or epidermal toxic necrolysis have been reported in association with the use of cefotaxime. The patient should be advised of the need for medical advice if such reactions occur.
Complications related to Clostridium difficile
During treatment or after it has ended, pseudomembranous colitis can develop as a result of the excessive growth of drug-resistant bacteria Clostridium difficile. In case of diarrhea, the possibility of this complication should be considered. In mild cases, it is sufficient to discontinue the drug; in severe cases, after discontinuation of the drug, adequate hydration of the patient should be ensured, the electrolyte reserve should be replenished, and a study should be performed to detect bacteria. If C. Difficile is found, metronidazole or vancomycin should Gloryfen used orally. Do not administer drugs that inhibit peristalsis or other drugs that have an astringent effect.
Caution should be exercised when using cefotaxime in patients with a history of inflammatory bowel disease, especially colitis.
Patients with kidney failure
Patients with renal failure should receive a correspondingly reduced dose depending on creatinine clearance. Caution should be exercised if cefotaxime is administered in combination with aminoglycosides or other nephrotoxic drugs. Renal function should be monitored in these patients, in the elderly, and in patients who have previously had impaired renal function.
High doses of beta-lactam antibiotics, including cefotaxime, especially in patients with renal failure, can cause encephalopathy (impaired consciousness, uncoordinated movements and convulsions). The patient should be advised of the need for medical advice if such reactions occur.
Leukopenia, neutropenia, and rarely agranulocytosis can occur during cefotaxime therapy, especially if the course Gloryfen treatment is long. If the course of treatment is more than 7-10 days, the white blood cell count should be monitored and treatment discontinued if neutropenia appears. Several cases of eosinophilia and thrombocytopenia have been reported, rapidly disappearing after discontinuation of treatment. Hemolytic anemia cases have also been reported.
Like any antibiotic, the use of cefotaxime can lead to resistance, as a result of which the drug may become ineffective. This must be taken into account in case of recurrence of infection and appropriate therapy should be prescribed.
Effect on laboratory results
Gloryfen does not affect the results of enzymatic tests that detect sugar in the urine. Cefotaxime, like other cephalosporins, can cause the appearance of a false positive Coombs test result.
